Evidence map›Paper›PMID 30992322›Full record

ArticleCancer research2019

A Human Organotypic Microfluidic Tumor Model Permits Investigation of the Interplay between Patient-Derived Fibroblasts and Breast Cancer Cells.

Danh D Truong, Alexander Kratz, Jin G Park, Eric S Barrientos, Harpinder Saini, Toan Nguyen, Barbara Pockaj, Ghassan Mouneimne, Joshua LaBaer, Mehdi Nikkhah

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 138 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Modeling CAF-tumor interactions to overcome therapy resistance.Journal of experimental & clinical cancer research : CR · 2026
    Review
  10. Article
  11. Microphysiological systems for metastasis research: a stepwise approach.Cellular oncology (Dordrecht, Netherlands) · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Danh D TruongSchool of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona.
Alexander KratzSchool of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona.
Jin G ParkVirginia G. Piper Biodesign Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, Arizona.ORCID 0000-0001-6481-9590
Eric S BarrientosSchool of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona.
Harpinder SainiSchool of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona.
Toan NguyenSchool of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona.
Barbara PockajDepartment of Surgery, Mayo Clinic, Phoenix, Arizona.
Ghassan MouneimneUniversity of Arizona Cancer Center, Tucson, Arizona.
Joshua LaBaerVirginia G. Piper Biodesign Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, Arizona.
Mehdi NikkhahSchool of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona. mnikkhah@asu.edu.
Arizona State University · USMayo Clinic Hospital · USUniversity of Arizona · US

Funding

Novel Mechanism of Breast Cancer Invasion Prevention by Estrogen ReceptorR01CA196885 · NCI · UNIVERSITY OF ARIZONA · PI MOUNEIMNE, GHASSAN · 2015 to 2019
$1.9M
NCI NIH HHS R01 CA196885
6 · The paper itself

Abstract

Tumor-stroma interactions significantly influence cancer cell metastasis and disease progression. These interactions are partly comprised of the cross-talk between tumor and stromal fibroblasts, but the key molecular mechanisms within the cross-talk that govern cancer invasion are still unclear. Here, we adapted our previously developed microfluidic device as a 3D

Indexed as

Tumor MicroenvironmentBreast NeoplasmsCancer-Associated FibroblastsCell MovementCoculture TechniquesFemaleFibroblastsGene Expression ProfilingHumansMembrane GlycoproteinsMicrofluidic Analytical TechniquesModels, BiologicalNeoplasm InvasivenessOrganoidsGPNMB protein, humanMembrane Glycoproteins

Identifiers

PMID30992322
PMCPMC6664809
OpenAlexW2938744143

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.